Evidence map›Paper›PMID 26747775›Full record

ArticleInvestigative ophthalmology & visual science2015

Primed Mycobacterial Uveitis (PMU): Histologic and Cytokine Characterization of a Model of Uveitis in Rats.

Kathryn L Pepple, Lauren Rotkis, Jennifer Van Grol, Leslie Wilson, Angela Sandt, Deborah L Lam, Eric Carlson, Russell N Van Gelder

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Tubercular serpiginous choroiditis.Journal of ophthalmic inflammation and infection · 2022
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. CD83Journal of cellular and molecular medicine · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kathryn L PeppleDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States.
Lauren RotkisDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States.
Jennifer Van GrolAlcon Research Laboratories, Fort Worth, Texas, United States.
Leslie WilsonDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States.
Angela SandtDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States.
Deborah L LamDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States.
Eric CarlsonAlcon Research Laboratories, Fort Worth, Texas, United States.
Russell N Van GelderDepartment of Ophthalmology, University of Washington, Seattle, Washington, United States 3Department of Biological Structure, University of Washington, Seattle, Washington, United States 4Department of Pathology, University of Washington, Seattle, Washin.
University of Washington · USAlcon (United States) · US

Funding

Vision Research CoreP30EY001730 · NEI · UNIVERSITY OF WASHINGTON · PI JAMES Bryant HURLEY · 1985 to 2026
$23.5M
The role of the innate and adaptive immune system in a novel model of uveitK08EY023998 · NEI · UNIVERSITY OF WASHINGTON · PI PEPPLE, KATHRYN · 2014 to 2018
$1.1M
NEI NIH HHS K08 EY023998NEI NIH HHS K08EY023998NEI NIH HHS P30 EY001730Wellcome Trust
6 · The paper itself

Abstract

purposeThe purpose of this study was to compare the histologic features and cytokine profiles of experimental autoimmune uveitis (EAU) and a primed mycobacterial uveitis (PMU) model in rats.

methodsIn Lewis rats, EAU was induced by immunization with interphotoreceptor binding protein peptide, and PMU was induced by immunization with a killed mycobacterial extract followed by intravitreal injection of the same extract. Clinical course, histology, and the cytokine profiles of the aqueous and vitreous were compared using multiplex bead fluorescence immunoassays.

resultsPrimed mycobacterial uveitis generates inflammation 2 days after intravitreal injection and resolves spontaneously 14 days later. CD68+ lymphocytes are the predominant infiltrating cells and are found in the anterior chamber, surrounding the ciliary body and in the vitreous. In contrast to EAU, no choroidal infiltration or retinal destruction is noted. At the day of peak inflammation, C-X-C motif ligand 10 (CXCL10), IL-1β, IL-18, and leptin were induced in the aqueous of both models. Interleukin-6 was induced 2-fold in the aqueous of PMU but not EAU. Cytokines elevated in the aqueous of EAU exclusively include regulated on activation, normal T cell expressed and secreted (RANTES), lipopolysaccharide-induced CXC chemokine (LIX), growth-related oncogene/keratinocyte chemokine (GRO/KC), VEGF, monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α), and IL-17A. In the vitreous, CXCL10, GRO/KC, RANTES, and MIP-1α were elevated in both models. Interleukin-17A and IL-18 were elevated exclusively in EAU.

conclusionsPrimed mycobacterial uveitis generates an acute anterior and intermediate uveitis without retinal involvement. Primed mycobacterial uveitis has a distinct proinflammatory cytokine profile compared with EAU, suggesting PMU is a good complementary model for study of immune-mediated uveitis. CXCL10, a proinflammatory cytokine, was increased in the aqueous and vitreous of both models and may be a viable therapeutic target.

Indexed as

AnimalsCytokinesDisease Models, AnimalEye Infections, BacterialFemaleMycobacterium tuberculosisRatsRats, Inbred LewUveitisCytokines

Identifiers

PMID26747775
PMCPMC4699411
OpenAlexW2416061891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.